Related Experiment Videos
Platelet transfusions in advanced hematological malignancies: a position paper
J M Lassauniere1, M Bertolino, M Hunault
1Center for Palliative Care, Hotel-Dieu, Paris, France.
Journal of Palliative Care
|January 1, 1996
Summary
Hematological malignancy patients require transfusions, prompting proposals to manage costs. Recommendations include clear transfusion criteria, patient education, and encouraging home transfusions to optimize care and resource use.
Area of Science:
- Hematology
- Transfusion Medicine
- Oncology
Background:
- Advanced-stage hematological malignancies (HM) necessitate frequent transfusions.
- Increasing administrative pressure and limited hospital budgets necessitate cost-saving strategies for transfusions.
- A multidisciplinary expert panel addressed the need for updated transfusion guidelines.
Purpose of the Study:
- To develop proposals for optimizing platelet transfusion practices in hematological malignancy patients.
- To define advanced-stage disease and establish clear indications for platelet transfusion.
- To propose strategies for cost containment while ensuring adequate patient care.
Main Methods:
- Convening an expert multidisciplinary panel in hematology.
- Formulating a working party to develop specific proposals.
- Reviewing current transfusion practices and patient needs.
Main Results:
- Platelet transfusions are indicated for bleeding due to low platelet counts.
- Patients should be fully informed about transfusion criteria.
- Physicians require training for urgent transfusion assessment.
- Home transfusion practices should be encouraged.
Conclusions:
- Implementing defined criteria and enhanced education can optimize platelet transfusion use in HM.
- Encouraging home transfusions may improve patient convenience and potentially reduce healthcare system costs.
- These proposals aim to balance cost-effectiveness with high-quality patient care in hematology services.